VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,413 | -98.3% | 13,598 | -95.4% | 0.00% | -100.0% |
| Q2 2023 | $7,298,338 | -4.7% | 297,527 | -9.6% | 0.02% | -14.8% |
| Q1 2023 | $7,656,318 | +349.2% | 329,021 | +388.6% | 0.03% | +350.0% |
| Q4 2022 | $1,704,476 | -45.2% | 67,344 | -58.2% | 0.01% | -57.1% |
| Q3 2022 | $3,109,000 | -63.7% | 161,239 | -52.1% | 0.01% | -61.1% |
| Q2 2022 | $8,567,000 | +100.2% | 336,326 | +102.1% | 0.04% | +140.0% |
| Q1 2022 | $4,280,000 | +80.1% | 166,391 | +193.2% | 0.02% | +87.5% |
| Q4 2021 | $2,376,000 | +313.2% | 56,754 | +328.9% | 0.01% | +300.0% |
| Q3 2021 | $575,000 | +52.1% | 13,232 | +65.2% | 0.00% | +100.0% |
| Q2 2021 | $378,000 | +0.8% | 8,008 | +9.5% | 0.00% | -50.0% |
| Q1 2021 | $375,000 | -18.1% | 7,313 | -57.3% | 0.00% | 0.0% |
| Q4 2020 | $458,000 | -71.6% | 17,131 | -56.5% | 0.00% | -75.0% |
| Q2 2020 | $1,615,000 | – | 39,407 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |